Your browser doesn't support javascript.
Sixteen novel lineages of SARS-CoV-2 in South Africa.
Tegally, Houriiyah; Wilkinson, Eduan; Lessells, Richard J; Giandhari, Jennifer; Pillay, Sureshnee; Msomi, Nokukhanya; Mlisana, Koleka; Bhiman, Jinal N; von Gottberg, Anne; Walaza, Sibongile; Fonseca, Vagner; Allam, Mushal; Ismail, Arshad; Glass, Allison J; Engelbrecht, Susan; Van Zyl, Gert; Preiser, Wolfgang; Williamson, Carolyn; Petruccione, Francesco; Sigal, Alex; Gazy, Inbal; Hardie, Diana; Hsiao, Nei-Yuan; Martin, Darren; York, Denis; Goedhals, Dominique; San, Emmanuel James; Giovanetti, Marta; Lourenço, José; Alcantara, Luiz Carlos Junior; de Oliveira, Tulio.
  • Tegally H; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Wilkinson E; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Lessells RJ; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Giandhari J; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Pillay S; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Msomi N; Discipline of Virology, University of KwaZulu-Natal, Durban, South Africa.
  • Mlisana K; National Health Laboratory Service, Springbok, South Africa.
  • Bhiman JN; National Institute For Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.
  • von Gottberg A; National Institute For Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.
  • Walaza S; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Fonseca V; National Institute For Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.
  • Allam M; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Ismail A; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Glass AJ; National Institute For Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.
  • Engelbrecht S; National Institute For Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.
  • Van Zyl G; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Preiser W; Department of Molecular Pathology, Lancet Laboratories, Johannesburg, South Africa.
  • Williamson C; Division of Medical Virology at NHLS Tygerberg Hospital, Stellenbosch University, Stellenbosch, South Africa.
  • Petruccione F; Division of Medical Virology at NHLS Tygerberg Hospital, Stellenbosch University, Stellenbosch, South Africa.
  • Sigal A; Division of Medical Virology at NHLS Tygerberg Hospital, Stellenbosch University, Stellenbosch, South Africa.
  • Gazy I; Division of Medical Virology at NHLS Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
  • Hardie D; Centre for Quantum Technology, University of KwaZulu-Natal, Durban, South Africa.
  • Hsiao NY; National Institute for Theoretical Physics (NITheP), KwaZulu-Natal, South Africa.
  • Martin D; Africa Health Research Institute, Durban, South Africa.
  • York D; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Goedhals D; Max Planck Institute for Infection Biology, Berlin, Germany.
  • San EJ; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Giovanetti M; Division of Medical Virology at NHLS Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
  • Lourenço J; Division of Medical Virology at NHLS Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
  • Alcantara LCJ; Division of Computational Biology, Department of Integrative Biomedical Sciences, Institute of Infectious Diseases and Molecular medicine, The University of Cape Town, Cape Town, South Africa.
  • de Oliveira T; Molecular Diagnostics Services, Durban, South Africa.
Nat Med ; 27(3): 440-446, 2021 03.
Article in English | MEDLINE | ID: covidwho-1319035
ABSTRACT
The first severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in South Africa was identified on 5 March 2020, and by 26 March the country was in full lockdown (Oxford stringency index of 90)1. Despite the early response, by November 2020, over 785,000 people in South Africa were infected, which accounted for approximately 50% of all known African infections2. In this study, we analyzed 1,365 near whole genomes and report the identification of 16 new lineages of SARS-CoV-2 isolated between 6 March and 26 August 2020. Most of these lineages have unique mutations that have not been identified elsewhere. We also show that three lineages (B.1.1.54, B.1.1.56 and C.1) spread widely in South Africa during the first wave, comprising ~42% of all infections in the country at the time. The newly identified C lineage of SARS-CoV-2, C.1, which has 16 nucleotide mutations as compared with the original Wuhan sequence, including one amino acid change on the spike protein, D614G (ref. 3), was the most geographically widespread lineage in South Africa by the end of August 2020. An early South African-specific lineage, B.1.106, which was identified in April 2020 (ref. 4), became extinct after nosocomial outbreaks were controlled in KwaZulu-Natal Province. Our findings show that genomic surveillance can be implemented on a large scale in Africa to identify new lineages and inform measures to control the spread of SARS-CoV-2. Such genomic surveillance presented in this study has been shown to be crucial in the identification of the 501Y.V2 variant in South Africa in December 2020 (ref. 5).
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Variants Limits: Humans Country/Region as subject: Africa Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2021 Document Type: Article Affiliation country: S41591-021-01255-3

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Variants Limits: Humans Country/Region as subject: Africa Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2021 Document Type: Article Affiliation country: S41591-021-01255-3